March 9, 2021
Top-tier and second-tier pharmaceutical companies are in for price reductions of around 2-4% in Japan’s first “off-year” drug re-pricing next month, while mid-sized players expect deeper cuts of 6-8%, with some of them even bracing for double-digit slashes, a Jiho...read more